Senior insider sale
Chief Medical Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$188.6K
13.04K shares
What this filing means
BEDROSIAN CAMILLE L plans to sell 13.04K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $188.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001326969-26-000002
Officer· Chief Medical Officer
Since Mar 2026
13.04K
Shares to sell
$188.6K
Approx. market value
17.11K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
N/A
3/2/2026
17.11KTotal acquired17.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units N/A | 17.11K | — |
| Total | 17.11K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.58K
Market value
$94.4K
12/1/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.46K
Market value
$94.2K
3/2/2026
Total
Units
13.04K
Value
$188.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 6.58K | $94.4K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 6.46K | $94.2K | NASDAQ | Planned |
| Total | 13.04K | $188.6K | ||